Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients

Thromb Res. 1999 Apr 1;94(1):65-8. doi: 10.1016/s0049-3848(98)00206-0.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Cost-Benefit Analysis*
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Venous Thrombosis / economics
  • Venous Thrombosis / prevention & control*

Substances

  • Heparin, Low-Molecular-Weight
  • Heparin